Sandoz Canada
News Release
Introducing Jubbonti® and Wyost®, the first denosumab biosimilars on the Canadian market
— Jubbonti® and Wyost® are first denosumab biosimilars available in Canada, reflecting the Sandoz Purpose of pioneering access for patients — Jubbonti® and...
News Release
Sandoz Canada achieves carbon neutral certification for its commercial operations
Sandoz Canada head office and sales force operations certified carbon neutral by LCL Engineering, Environment & Sustainable DevelopmentCO2 emissions offset through the purchase...
News Release
Sandoz signs landmark supply and manufacturing agreement
Sandoz signs 10-year agreement with partner Delpharm, a global pharmaceutical developer and contract manufacturerAgreement will secure a reliable supply of affordable, quality sterile...
